Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. The Diabetic Retinopathy Vitrectomy Study Research Group
Six hundred sixteen eyes with recent severe diabetic vitreous hemorrhage
reducing visual acuity to 5/200 or less for at least one month were
randomly assigned to either early vitrectomy or deferral of vitrectomy for
one year. After two years of follow-up, 25% of the early vitrectomy group
had visual acuity of 10/20 or better compared with 15% in the deferral
group (P = .01). In patients with Type I diabetes, who were on the average
younger and had more-severe proliferative retinopathy, there was a
clear-cut advantage for early vitrectomy, as reflected in the percentage of
eyes recovering visual acuity of 10/20 or better (36% vs 12% in the
deferral group, P = .0001). No such advantage was found in the Type II
diabetes group (16% in the early group vs 18% in the deferral group), but
evidence that this advantage differed by diabetes type was of borderline
significance.
Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy
Yorston et al.
Br. J. Ophthalmol. 2008;92:365-368.
ABSTRACT
| FULL TEXT
Management of Diabetic Retinopathy: A Systematic Review
Mohamed et al.
JAMA 2007;298:902-916.
ABSTRACT
| FULL TEXT
Reduction of Diabetic Macular Edema by Oral Administration of the Kinase Inhibitor PKC412
Campochiaro
IOVS 2004;45:922-931.
ABSTRACT
| FULL TEXT
Diabetic Retinopathy
Frank
NEJM 2004;350:48-58.
FULL TEXT
The Impact of Clinical Trials on the Treatment of Diabetes Mellitus
Nathan
J. Clin. Endocrinol. Metab. 2002;87:1929-1937.
ABSTRACT
| FULL TEXT
How Many Steps of Progression of Diabetic Retinopathy Are Meaningful?: The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein et al.
Arch Ophthalmol 2001;119:547-553.
ABSTRACT
| FULL TEXT
Treatment of Diabetic Retinopathy
Ferris et al.
NEJM 1999;341:667-678.
FULL TEXT
Practice Patterns in Diabetic Retinopathy: Part 1: Analysis of Retinopathy Follow-up
Khadem et al.
Arch Ophthalmol 1999;117:815-820.
ABSTRACT
| FULL TEXT
The CONSORT Statement: Will It Lead to Improved Reporting of Clinical Trials in Ophthalmology?
Hawkins
Arch Ophthalmol 1999;117:677-680.
FULL TEXT
Prevention and Treatment of the Complications of Diabetes Mellitus
Clark and Lee
NEJM 1995;332:1210-1217.
FULL TEXT
Long-Term Complications of Diabetes Mellitus
Nathan
NEJM 1993;328:1676-1685.
FULL TEXT